Total properties:
46
|
|
Patent #:
|
|
Issue Dt:
|
07/10/2012
|
Application #:
|
12305648
|
Filing Dt:
|
11/06/2009
|
Publication #:
|
|
Pub Dt:
|
04/08/2010
| | | | |
Title:
|
POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
01/02/2018
|
Application #:
|
13127439
|
Filing Dt:
|
05/03/2011
|
Publication #:
|
|
Pub Dt:
|
09/15/2011
| | | | |
Title:
|
ANTI-KIDNEY ASSOCIATED ANTIGEN 1 (KAAG1) ANTIBODIES
|
|
|
Patent #:
|
|
Issue Dt:
|
11/12/2013
|
Application #:
|
13187424
|
Filing Dt:
|
07/20/2011
|
Publication #:
|
|
Pub Dt:
|
04/19/2012
| | | | |
Title:
|
ANTIBODIES THAT SPECIFICALLY BLOCK THE BIOLOGICAL ACTIVITY OF KIDNEY ASSOCIATED ANTIGEN 1 (KAAG1)
|
|
|
Patent #:
|
|
Issue Dt:
|
01/20/2015
|
Application #:
|
14036204
|
Filing Dt:
|
12/10/2013
|
Publication #:
|
|
Pub Dt:
|
05/22/2014
| | | | |
Title:
|
ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
04/03/2018
|
Application #:
|
14434816
|
Filing Dt:
|
04/10/2015
|
Publication #:
|
|
Pub Dt:
|
10/08/2015
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/11/2020
|
Application #:
|
14434818
|
Filing Dt:
|
04/10/2015
|
Publication #:
|
|
Pub Dt:
|
10/01/2015
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTI-PSMA ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
06/30/2020
|
Application #:
|
14434821
|
Filing Dt:
|
04/10/2015
|
Publication #:
|
|
Pub Dt:
|
10/22/2015
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
04/03/2018
|
Application #:
|
14434823
|
Filing Dt:
|
04/10/2015
|
Publication #:
|
|
Pub Dt:
|
10/08/2015
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
03/20/2018
|
Application #:
|
14434826
|
Filing Dt:
|
04/10/2015
|
Publication #:
|
|
Pub Dt:
|
09/24/2015
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTI-CD22 ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
07/19/2016
|
Application #:
|
14558186
|
Filing Dt:
|
12/02/2014
|
Publication #:
|
|
Pub Dt:
|
07/30/2015
| | | | |
Title:
|
ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
04/24/2018
|
Application #:
|
15028589
|
Filing Dt:
|
04/11/2016
|
Publication #:
|
|
Pub Dt:
|
09/15/2016
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/01/2018
|
Application #:
|
15028591
|
Filing Dt:
|
04/11/2016
|
Publication #:
|
|
Pub Dt:
|
09/01/2016
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
11/28/2017
|
Application #:
|
15137368
|
Filing Dt:
|
04/25/2016
|
Publication #:
|
|
Pub Dt:
|
10/20/2016
| | | | |
Title:
|
ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
09/22/2020
|
Application #:
|
15529622
|
Filing Dt:
|
05/25/2017
|
Publication #:
|
|
Pub Dt:
|
09/14/2017
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
03/24/2020
|
Application #:
|
15811545
|
Filing Dt:
|
11/13/2017
|
Publication #:
|
|
Pub Dt:
|
10/11/2018
| | | | |
Title:
|
ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
07/28/2020
|
Application #:
|
15884665
|
Filing Dt:
|
01/31/2018
|
Publication #:
|
|
Pub Dt:
|
06/21/2018
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTI-CD22 ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
09/22/2020
|
Application #:
|
15897835
|
Filing Dt:
|
02/15/2018
|
Publication #:
|
|
Pub Dt:
|
09/06/2018
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/13/2020
|
Application #:
|
15911592
|
Filing Dt:
|
03/05/2018
|
Publication #:
|
|
Pub Dt:
|
07/12/2018
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
08/10/2021
|
Application #:
|
16164656
|
Filing Dt:
|
10/18/2018
|
Publication #:
|
|
Pub Dt:
|
04/25/2019
| | | | |
Title:
|
METHOD FOR TREATING BREAST CANCER
|
|
|
Patent #:
|
|
Issue Dt:
|
01/28/2020
|
Application #:
|
16197891
|
Filing Dt:
|
11/21/2018
|
Publication #:
|
|
Pub Dt:
|
07/18/2019
| | | | |
Title:
|
COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATE
|
|
|
Patent #:
|
|
Issue Dt:
|
07/12/2022
|
Application #:
|
16484313
|
Filing Dt:
|
08/07/2019
|
Publication #:
|
|
Pub Dt:
|
03/18/2021
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
11/02/2021
|
Application #:
|
16484328
|
Filing Dt:
|
08/07/2019
|
Publication #:
|
|
Pub Dt:
|
04/01/2021
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16605692
|
Filing Dt:
|
10/16/2019
|
Publication #:
|
|
Pub Dt:
|
04/30/2020
| | | | |
Title:
|
COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16605701
|
Filing Dt:
|
10/16/2019
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
Title:
|
COMBINATION THERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
03/07/2023
|
Application #:
|
16605708
|
Filing Dt:
|
10/16/2019
|
Publication #:
|
|
Pub Dt:
|
01/20/2022
| | | | |
Title:
|
COMBINATION THERAPY WITH AN ANTI-CD25 ANTIBODY-DRUG CONJUGATE
|
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2022
|
Application #:
|
16622649
|
Filing Dt:
|
12/13/2019
|
Publication #:
|
|
Pub Dt:
|
06/04/2020
| | | | |
Title:
|
DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC
|
|
|
Patent #:
|
|
Issue Dt:
|
08/30/2022
|
Application #:
|
16622663
|
Filing Dt:
|
12/13/2019
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
Title:
|
DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD25 ADC
|
|
|
Patent #:
|
|
Issue Dt:
|
07/18/2023
|
Application #:
|
16684222
|
Filing Dt:
|
11/14/2019
|
Publication #:
|
|
Pub Dt:
|
12/24/2020
| | | | |
Title:
|
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16806910
|
Filing Dt:
|
03/02/2020
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
07/04/2023
|
Application #:
|
16883139
|
Filing Dt:
|
05/26/2020
|
Publication #:
|
|
Pub Dt:
|
10/01/2020
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTI-CD22 ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/03/2023
|
Application #:
|
16934319
|
Filing Dt:
|
07/21/2020
|
Publication #:
|
|
Pub Dt:
|
11/05/2020
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16968143
|
Filing Dt:
|
08/06/2020
|
Publication #:
|
|
Pub Dt:
|
06/09/2022
| | | | |
Title:
|
TREATMENT OF CAR T-CELL TOXICITY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16987348
|
Filing Dt:
|
08/06/2020
|
Publication #:
|
|
Pub Dt:
|
05/13/2021
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTI-PSMA ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
10/10/2023
|
Application #:
|
16997862
|
Filing Dt:
|
08/19/2020
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17006681
|
Filing Dt:
|
08/28/2020
|
Publication #:
|
|
Pub Dt:
|
04/22/2021
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17057486
|
Filing Dt:
|
11/20/2020
|
Publication #:
|
|
Pub Dt:
|
04/14/2022
| | | | |
Title:
|
MOLECULAR ADJUVANT
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17259466
|
Filing Dt:
|
01/11/2021
|
Publication #:
|
|
Pub Dt:
|
04/27/2023
| | | | |
Title:
|
COMBINATION THERAPY
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17271108
|
Filing Dt:
|
02/24/2021
|
Publication #:
|
|
Pub Dt:
|
10/21/2021
| | | | |
Title:
|
COMBINATION THERAPY
|
|
|
Patent #:
|
|
Issue Dt:
|
11/01/2022
|
Application #:
|
17380859
|
Filing Dt:
|
07/20/2021
|
Publication #:
|
|
Pub Dt:
|
01/20/2022
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
|
Issue Dt:
|
05/07/2024
|
Application #:
|
17389582
|
Filing Dt:
|
07/30/2021
|
Publication #:
|
|
Pub Dt:
|
02/03/2022
| | | | |
Title:
|
ANTI-IL13R ALPHA2 ANTIBODIES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17414622
|
Filing Dt:
|
06/16/2021
|
Publication #:
|
|
Pub Dt:
|
11/03/2022
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE RESISTANCE
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17481918
|
Filing Dt:
|
09/22/2021
|
Publication #:
|
|
Pub Dt:
|
03/31/2022
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
11/14/2023
|
Application #:
|
17484467
|
Filing Dt:
|
09/24/2021
|
Publication #:
|
|
Pub Dt:
|
01/13/2022
| | | | |
Title:
|
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17617875
|
Filing Dt:
|
12/09/2021
|
Publication #:
|
|
Pub Dt:
|
09/29/2022
| | | | |
Title:
|
COMBINATION THERAPY COMPRISING AN ANTI-CD19 ANTIBODY DRUG CONJUGATE AND A PI3K INHIBITOR OR A SECONDARY AGENT
|
|
|
Patent #:
|
|
Issue Dt:
|
03/26/2024
|
Application #:
|
17699065
|
Filing Dt:
|
03/18/2022
|
Publication #:
|
|
Pub Dt:
|
09/08/2022
| | | | |
Title:
|
DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17780154
|
Filing Dt:
|
05/26/2022
|
Publication #:
|
|
Pub Dt:
|
03/30/2023
| | |
PCT #:
|
EP2020081361
|
Title:
|
COMBINATION THERAPY
|
|